| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/11/2009 | CA2548834C Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 08/11/2009 | CA2476520C Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2417089C Palatable oral coenzyme q liquid |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2392013C Analgesic compositions containing buprenorphine in combination with naloxone, naltrexone or nalmefene |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/11/2009 | CA2382013C Pharmaceutical solutions of levosimendan |
| 08/11/2009 | CA2358361C Stable compositions for parenteral administration and their use |
| 08/11/2009 | CA2336432C Monolayer sugar-coated tablet and process for preparation thereof |
| 08/11/2009 | CA2315890C Rate controlling membranes for controlled drug delivery devices |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2241572C Apo-2 ligand |
| 08/06/2009 | WO2009097570A2 Intralymphatic chemotherapy drug carriers |
| 08/06/2009 | WO2009097508A2 Methods and compositions for wound healing |
| 08/06/2009 | WO2009097443A2 Liquid formulations of compounds active at sulfonylurea receptors |
| 08/06/2009 | WO2009097349A1 Therapeutic compositions |
| 08/06/2009 | WO2009096810A1 Method for producing a water-soluble pharmaceutical composition |
| 08/06/2009 | WO2009096560A1 Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/06/2009 | WO2009096559A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | WO2009096487A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | WO2009096354A1 Fentanyl-containing patch for external use |
| 08/06/2009 | WO2009096315A1 Adhesive patch |
| 08/06/2009 | WO2009096245A1 Pharmaceutical composition and combined agent |
| 08/06/2009 | WO2009095670A1 Soft gel capsules |
| 08/06/2009 | WO2009095560A1 Pharmaceutical compositions containing azetidine derivatives |
| 08/06/2009 | WO2009095485A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative |
| 08/06/2009 | WO2009095480A1 Improved antitumoral treatments |
| 08/06/2009 | WO2009095479A2 Prodrug comprising a self-cleavable linker |
| 08/06/2009 | WO2009095450A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 08/06/2009 | WO2009095057A2 Transdermal therapeutic system having urea components |
| 08/06/2009 | WO2009094846A1 Insulin nasal powder inhalation |
| 08/06/2009 | WO2009094752A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009094751A1 An anti-cancer cytotoxic monoclonal antibody |
| 08/06/2009 | WO2009007764A3 Pharmaceutical preparations containing highly volatile silicones |
| 08/06/2009 | WO2008149238A3 Formulation of meningitis vaccines |
| 08/06/2009 | WO2008079897A3 Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 08/06/2009 | US20090197976 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 08/06/2009 | US20090197975 Compositions formulated for solvent-regulated drug release |
| 08/06/2009 | US20090197974 Natural dietary supplement tablet |
| 08/06/2009 | US20090197973 Method for preparing emulsion or dispersion, and foodstuff, skin externals and medicaments containing emulsion or dispersion obtained by the method |
| 08/06/2009 | US20090197972 Bone replacement material comprising crystalline phases |
| 08/06/2009 | US20090197948 Skin External Preparation |
| 08/06/2009 | US20090197849 Transdermal and topical administration of drugs using basic permeation enhancers |
| 08/06/2009 | US20090197847 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 08/06/2009 | US20090197846 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 08/06/2009 | US20090197841 Inhalant Propellant-Free Aerosol Formulation |
| 08/06/2009 | US20090197821 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | US20090196931 Therapeutic inhibitor of vascular smooth muscle cells |
| 08/06/2009 | US20090196925 Natural product coating for tablets |
| 08/06/2009 | US20090194894 Residual solvent extraction method and microparticles produced thereby |
| 08/06/2009 | DE102008006791A1 Transdermales Therapeutisches System mit Harnstoff-Komponente Transdermal therapeutic system with urea component |
| 08/06/2009 | CA2713946A1 Adhesive patch |
| 08/06/2009 | CA2713813A1 Intralymphatic chemotherapy drug carriers |
| 08/06/2009 | CA2713679A1 Orally rapidly disintegrating tablet comprising imidafenacin |
| 08/06/2009 | CA2713677A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 08/06/2009 | CA2713673A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 08/06/2009 | CA2713571A1 Pharmaceutical composition or combination drug |
| 08/06/2009 | CA2713459A1 Improved antitumoral treatments |
| 08/06/2009 | CA2713339A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 08/06/2009 | CA2713266A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative |
| 08/06/2009 | CA2712224A1 Prodrug comprising a drug linker conjugate |
| 08/06/2009 | CA2711774A1 Fentanyl-containing patch for external use |
| 08/06/2009 | CA2710640A1 Transdermal therapeutic system having urea components |
| 08/06/2009 | CA2705369A1 Biomaterial for the controlled delivery of ingredients |
| 08/06/2009 | CA2699916A1 Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| 08/05/2009 | EP2085406A1 Long lasting insulin derivatives and methods thereof |
| 08/05/2009 | EP2085097A1 Highly water-dispersible powder and method of producing the same |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085088A1 Adhesive preparation |
| 08/05/2009 | EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 08/05/2009 | EP2085079A2 Process for stabilizing famotidine |
| 08/05/2009 | EP2085074A1 Drug microparticles |
| 08/05/2009 | EP2085073A1 Drug microparticles |
| 08/05/2009 | EP2085072A1 Drug microparticles |
| 08/05/2009 | EP2084183A1 Pegylated pth as pth receptor modulators and uses thereof |
| 08/05/2009 | EP2083876A2 Methods of wound care and treatment |
| 08/05/2009 | EP2083870A1 Multimeric particles |
| 08/05/2009 | EP2083868A2 Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| 08/05/2009 | EP2083867A1 Inclusion complex of sibutramine and beta-cyclodextrin |
| 08/05/2009 | EP2083866A2 Lipidized interferon and uses thereof |
| 08/05/2009 | EP2083843A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 08/05/2009 | EP2083834A2 Macrocyclic lactone compounds and methods for their use |
| 08/05/2009 | EP2083833A2 Pharmaceutical anti-infective composition for inhalation. |
| 08/05/2009 | EP2083820A1 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 08/05/2009 | EP2083799A1 Micellar nanoparticles of chemical substances |
| 08/05/2009 | EP2083798A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| 08/05/2009 | EP2083797A1 Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
| 08/05/2009 | EP2083796A2 Enzyme inhibition using nanoparticles |
| 08/05/2009 | EP2083795A1 Semi-solid controlled release composition |
| 08/05/2009 | EP1793860B1 Composition and method for medical imaging of body cavities |
| 08/05/2009 | EP1765394B1 Methods for preparing immunogenic conjugates |
| 08/05/2009 | EP1751225B1 Thermoplastic films and methods for making |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 08/05/2009 | EP1706155A4 Polymeric micellar complexes and drug delivery vehicles thereof |
| 08/05/2009 | EP1624884A4 Somatostatin vectors |
| 08/05/2009 | EP1608340A4 A method of preparing gas-filled polymer matrix microparticles useful for delivering drug |
| 08/05/2009 | EP1581274B1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |